Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Glioma × Dexamethasone × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 136 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Vomiting 22 Recurrence 21 Leukemia 20 Neoplasms, Plasma Cell 17 Neoplasms 16 Nausea 12 Lymphoma 12 Prostatic Neoplasms 8 Burkitt Lymphoma 7 Immunoglobulin Light-chain Amyloidosis 6 Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Follicular 4 Hodgkin Disease 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Paraproteinemias 3 Lymphoma, Non-Hodgkin 3 Fallopian Tube Neoplasms 3 Smoldering Multiple Myeloma 2 Plasmacytoma 2 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2

Interventions

Temozolomide 6 Radiotherapy 6 Lomustine 5 Procarbazine 4 Bevacizumab 4 Vincristine 3 Carmustine 3 vorasidenib 1 contrast agent BR1 1 carmustine, poliferprosan 20 drug combination 1 Valproic Acid 1 Tranexamic Acid 1 TIC10 compound 1 Surgical Procedures, Operative 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Microbubbles 1 Isotretinoin 1 IL13-PE38 1 Fentanyl 1 Eflornithine 1 Donepezil 1 Dihematoporphyrin Ether 1 Dianhydrogalactitol 1 Dexamethasone 1 Dalteparin 1 Chemotherapy, Adjuvant 1 Aminolevulinic Acid 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06888817 2026-02-25

BRAINS

The Netherlands Cancer Institute

Phase 3 Recruiting

Brain Neoplasms, Glioma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡